NAGE
Niagen Bioscience, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$392.65M
P/E Ratio
24.65
EPS
$0.20
Beta
2.17
52W High
$14.69
52W Low
$4.16
50-Day MA
$4.77
200-Day MA
$6.96
Dividend Yield
—
Profit Margin
13.40%
Forward P/E
18.66
PEG Ratio
—
About Niagen Bioscience, Inc.
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | $129.42M |
| Gross Profit (TTM) | $83.19M |
| EBITDA | $15.08M |
| Operating Margin | 6.22% |
| Return on Equity | 28.30% |
| Return on Assets | 10.20% |
| Revenue/Share (TTM) | $1.64 |
| Book Value | $0.96 |
| Price-to-Book | 5.05 |
| Price-to-Sales (TTM) | 3.03 |
| EV/Revenue | 2.507 |
| EV/EBITDA | 20.61 |
| Quarterly Earnings Growth (YoY) | -41.60% |
| Quarterly Revenue Growth (YoY) | 16.20% |
| Shares Outstanding | $79.64M |
| Float | $52.87M |
| % Insiders | 29.25% |
| % Institutions | 41.38% |
Historical Volatility
HV 10-Day
55.79%
HV 20-Day
42.71%
HV 30-Day
44.59%
HV 60-Day
42.89%
HV Rank
39.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($13.60 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026